Immune Response to CagA Protein is Associated with Improved Platelet Count After Helicobacter pylori Eradication in Patients with Idiopathic Thrombocytopenic Purpura
- 15 January 2007
- journal article
- Published by Wiley in Helicobacter
- Vol. 12 (1) , 36-42
Abstract
Background: Improvement in platelet counts has been reported after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura (ITP). We examined the levels of serum markers of gastritis and anti‐CagA (cytotoxin‐associated gene A) IgG antibody in patients with ITP to investigate whether these factors are associated with the platelet response after H. pylori eradication therapy.Materials and methods: One hundred and sixteen consecutive patients with ITP were assessed for H. pylori infection by 13C‐urea breath test and serum H. pylori antibody test. Patients with H. pylori infection received eradication therapy. Before and after eradication therapy, we evaluated serum levels of gastrin, pepsinogen (PG)‐I, and PG‐II and the anti‐CagA IgG antibody titer.Results: H. pylori infection was found in 67 (58%) of the 116 patients with ITP. Fifty‐two infected patients received eradication therapy, which was successful in 44 patients (85%). Twenty‐seven patients (62%) showed an increased platelet count and were identified as responders. The duration of ITP was shorter in responders than in nonresponders (p = .017). There was no difference of the levels of gastrin and PGs between responders and nonresponders. Before eradication therapy, the serum anti‐CagA antibody titer did not differ significantly between responders and nonresponders. However, reduction in the anti‐CagA antibody titer after eradication therapy was significantly greater in responders than in nonresponders (p = .013).Conclusions: H. pylori eradication therapy improves the platelet count in H. pylori‐positive patients with ITP of short duration. Immune response of hosts to CagA protein of H. pylori may play a role in the pathogenesis of ITP.Keywords
This publication has 25 references indexed in Scilit:
- Biomarkers in Patients with Gastric Inflammation: A Systematic ReviewDigestion, 2005
- Infectious agents and human immune diseases: Lessons from Helicobacter pyloriThe American Journal of Medicine, 2005
- Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpuraThe American Journal of Medicine, 2005
- Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in JapanEuropean Journal of Clinical Investigation, 2005
- Characteristics of Helicobacter pylori‐Induced Gastritis and the Effect of H. pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic PurpuraHelicobacter, 2004
- Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?Blood, 2004
- Can Eradication Therapy for Helicobacter pylori Really Improve the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature ReviewInternational Journal of Hematology, 2003
- Platelet Recovery in Patients with Idiopathic Thrombocytopenic Purpura after Eradication of Helicobacter PyloriInternational Journal of Hematology, 2003
- Helicobacter pyloriInfectionNew England Journal of Medicine, 2002
- Helicobacter pylori and extra‐digestive diseasesJournal of Gastroenterology and Hepatology, 1999